THE INCREMENTAL COSTS OF CHOLANGIOSCOPIC BIOPSIES EXCEEDS THOSE OF FLUOROSCOPIC BIOPSIES WITHOUT ADDED DIAGNOSTIC YIELD

GASTROINTESTINAL ENDOSCOPY(2022)

引用 0|浏览6
暂无评分
摘要
Divya Chalikonda: NO financial relationship with a commercial interest | Daniel Scanlon: NO financial relationship with a commercial interest | Abhishek Agnihotri: NO financial relationship with a commercial interest | Brianna Shinn: NO financial relationship with a commercial interest | Austin Chiang: YES financial relationship with a commercial interest;Medtronic:Employment;Boston Scientific:Consulting;Exact Sciences:Consulting;Olympus:Consulting | Alexander Schlachterman: NO financial relationship with a commercial interest | Anand Kumar: YES financial relationship with a commercial interest;Olympus:Consulting | Thomas Kowalski: YES financial relationship with a commercial interest;BSCI:Consulting;Olympus:Consulting;Interscope:Consulting | David Loren: YES financial relationship with a commercial interest;Boston Scientific:Consulting;Olympus America:Consulting;Ambu:Consulting;Pinnacle Biologics:Consulting
更多
查看译文
关键词
cholangioscopic biopsies exceeds,fluoroscopic biopsies,incremental costs
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要